Document And Entity Information
| Document And Entity Information | Oct. 10, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Oct. 10, 2022 |
| Entity Registrant Name | Cytokinetics, Incorporated |
| Entity Central Index Key | 0001061983 |
| Entity Emerging Growth Company | false |
| Securities Act File Number | 000-50633 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 94-3291317 |
| Entity Address, Address Line One | 350 Oyster Point Boulevard |
| Entity Address, City or Town | South San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94080 |
| City Area Code | (650) |
| Local Phone Number | 624-3000 |
| Entity Information, Former Legal or Registered Name | Not Applicable |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value |
| Trading Symbol | CYTK |
| Security Exchange Name | NASDAQ |